Grace Therapeutics (GRCE) Total Debt (2019 - 2021)

Grace Therapeutics has disclosed Total Debt across 2 years of filings, most recently posting $32000.0 for Q4 2021.

• In Q4 2021, Total Debt changed N/A year-over-year to $32000.0; the TTM figure through Dec 2021 stood at $32000.0 (changed N/A YoY), while the FY2019 annual figure was $1.4 million, changed N/A from the prior year.
• Total Debt came in at $32000.0 for Q4 2021 at Grace Therapeutics, down from $1.4 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $1.4 million in Q1 2019 to a low of $32000.0 in Q4 2021.